A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Cancer research in the U.S. doesn't rely on a single institution or funding stream − it's a complex ecosystem made up of ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Researchers from University of California San Diego have linked a bacterial toxin called colibactin to the increase in ...

A new study says a toxin caused by some strains of E. coli may be causing the rise in colon cancer in younger people.